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ABSTRACT
Dihydrofolate reductase (DHFR) gene expression is required for cell growth. The DHFR gene
promoter contains several GC elements capable of binding the transcription factor Spl. In this report
we have characterized the effect of protein(s) binding to these sequence elements in the Chinese
hamster DHFR promoter on transcription. We have constructed a series of deletions containing from
896 to 103 bp 5' to the start of translation. The protein binding domains have been mapped by DNAse
I footprint analysis using HeLa nuclear extract, and the function of the protein-binding elements
has been assessed by in vitro transcription and transient CAT expression. Maximal transcription
in vitro and CAT expression is obtained with a construct containing 3 GC elements extending to
position -184. Removal of GC element binding factor(s), by competition with an oligonucleotide
containing an Spl binding site, completely abolishes transcription in vitro and significantly diminishes
CAT expression. Ten-fold higher 'molar excess of competitor is required to abolish SV40 early
transcription, suggesting that the GC element interactions in the DHFR promoter are different from
those in the SV40 early region. Co-transfection of a DHFR CAT construct with an expressor of
Spl dramatically increased CAT expression in Drosophila cells.
INTRODUCTION
The enzyme dihydrofolate reductase (DHFR) is required for de novo synthesis of
thymidylate, purines, and glycine. DHFR is classified as a 'housekeeping' gene because
it is expressed in all growing eells and is required for maintenance of cell growth. DHFR
gene expression is regulated atl the level of transcription within the cell cycle of methotrexate-
resistant murine cells (1), and upon serum addition to quiescent methotrexate-resistant
murine cells (2).
The 5' flanking regions of the murine (3), hamster (4,5) and human (6) DHFR genes
have been cloned and sequenced. There is a striking degree of sequence conservation in
the 5' flanking sequence among these species. The DHFR promoter region does not contain
consensus CAAT or TATA elements, although there are conserved CAA elements
positioned 29 nucleotides upstream from both the major and minor transcription start sites;
in addition, several GC-elements are present. At least four other housekeeping genes,
thymidylate synthetase (7), hydroxymethylglutaryl CoA reductase (8), hypoxanthine guanine
phosphoribosyl transferase (9), and adenine deaminase (10), also contain multiple GC
elements, while lacking TATA and CAAT elements. In addition, some non-housekeeping
genes, including TGFax (11), rat malic enzyme (12), human c-Ha-ras (13), and the nerve
growth factor receptor gene (14), also contain multiple GC elements in the absence of
TATA and CAAT elements. There are many examples of gene promoters with GC elements
in addition to TATA and CAAT elements, including the SV40 early promoter.
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The transcription factor Spl was isolated from HeLa nuclea.r extracts on the basis of
its ability to bind selectively to the GC consensus element, G/TG/(A)GGCGG/MPuPuPy that
is repeated 6 times in the SV40 early promoter (Substitutions in parentheses occur in
sequence elements that bind Spl, but are not part of the 'consensus'. For review, 15).
More recently, protein fractions enriched in Spl have been shown to bind to promoter
regions of other genes, including Harvey ras, HIV-LTR, HSV-thymidine kinase,
metallothionein, and murine DHFR. A partially purified preparation of Spl enhances
transcription from these promoters when added to extracts depleted of this fraction (for
review, 15).
The role of Spl in transcriptional control is not understood at this time. A number of
findings suggest that although Spl binding can stimulate transcription, it is not the only,
nor the limiting factor controlling transcription of genes containing GC-elements. Spl binds
to a variety of promoters that are not obviously related (15). In three instances reported
thus far, other transcription factors, NF-A (16), API (17), and CTF/NF-I (18), bind to
promoter sequences proximal to the Spl binding domain. In addition, the binding of both
nuclear factor A (NF-A) and Spl is required for full activity of the human U2 snRNA
enhancer in vivo (17). However, there are no reports to date of transcription factors other
than Spl that bind 5' to the transcription start site and stimulate transcription of DHFR.
We have reported that the transcription factor, E2F binds 3' to the cap site of the major
transcription start and is required for full activity of the promoter (19).
The mouse DHFR promoter has been transcribed in vitro (20,21). In these reports it
was demonstrated that one GC box is sufficient to support transcription (20), and that a
GC box binding factor is required for transcription in vitro (21). Using the hamster promoter,
we have partially corroborated and extended DHFR promoter characterization.
We have characterized the hamster DHFR promoter at the level of in vitro protein binding
(DNAse I footprinting), in vitro transcription, and transient CAT expression. In this paper
we report that a DHFR promoter clone with one SpI binding site is not transcribed in
vitro in HeLa nuclear extract, and does not support transient expression of chloramphenicol
acetyl transferase (CAT) in HeLa cells. In vitro transcription and transient CAT expression
are approximately the same from clones extending from 184 base pairs (with 3 GC elements)
up to 900 base pairs 5' to the translation start . Furthermore, transcription in vitro from
a DHFR promoter clone with 4 GC elements is completely abolished by competition with
an Spl element oligonucleotide, and co-transfection of the same oligonucleotide reduces
CAT expression to levels obtained with a promoterless construct. In addition, co-transfection
of an Spl expression plasmid activates the DHFR promoter in Schneider cells.
MATERIALS AND METHODS
Cell Culture and Nuclear Extract Preparation
HeLa-S3 cells were grown in suspension culture and maintained at a density of 4-8 x 105
cells/ml in Joklik's modified essential media supplemented with 10% HyClone defined
calf serum and gentamycin/kanamycin. Nuclear extracts were prepared from the cells with
the following modifications to the method of Dignam et al. (22). After homogenization
of cells in hypotonic buffer 'A' (10mM Hepes, pH 7.9/10 mM KCl/0.75 mM
spermidine/0. 15 mM spermine/0. 1 mM EDTA/0. 1 mM EGTA), nuclei were recovered
by centrifugation at 30,000 xg for 30 seconds. Nuclei were then extracted in Buffer 'C'
(20mM Hepes, pH 7.9/0.2 mM EDTA/0.2 mM EGTA/2 mM DTT/25% glycerol/0. 15
mM spermine/0.75 mM spermidine/l.0 mM PMSF/0.4 M NaCl). The extract was
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recovered by centrifugation at 150,000 x g for 90 minutes followed by dialysis against a
buffer consisting of20mM Hepes, pH 7.95/20% glycerol/100 mM KCl/0.2 mM EDTA/0.2
mM EGTA/2mM DTT/l.0 mM PMSF/12.5 mM MgC12 The extract was frozen in
aliquots at -70°C.
Construction of DHFR Clones
The original genomic clone from which the DHFR promoter constructs were subcloned
is a 1290 bp Eco RI fragment that contains the region from -896 to +409 relative to
the AUG codon (4). The largest promoter construct we have studied, designated pDHF-896,
is a 874 bp Eco RI/Sty I fragment which contains the segment -896 to -22 relative to
the translation start. The clone designated pDHF-455 is a Sty I fragment containing the
DHFR sequence from -455 to -22. pDHF-324 was made from pDHF-455 by deletion
from the 5' multiple cloning region to the Sac II site. The clone pDHF-239 was derived
from -455 by digestion with Bss HII to yield a -239 to -22 fragment. The clone
pDHF-184 is a Nae I (pos. -184) to Sau 3a I (pos. -16) fragment, and pDHF-103 is
a Hae II (pos.-103) to Sau 3a I (pos. -16) fragment. pDHF-120 was made from
pDHF-103 by cloning a double stranded oligonucleotide containing 17 bp of DHFR
sequence and Sac I and Kpn I ends into the Sac I and Kpn I sites of the multiple cloning
region. Therefore, pDHF-120 has 7 bp of additional sequence between -103 and -104
of the DHFR promoter. The sequences were confirmed by dideoxy sequencing of the clones.
All of the clones are in the multiple cloning site of pUC18, and DH5 is the host strain.
For transient expression experiments, the bacterial chloramphenicol acetyl transferase gene
(CAT gene block, Pharmacia), a 751 bp Hind HI fragment, was subcloned 3' to these
promoter segments. A portion of pSV2CAT containing part of SV40 small t antigen
including the polyadenylation signal was inserted 3' to CAT. A promoter-less construct
consisting of the polyadenylated CAT fragment in pUC18 (pUC/CAT) served as a negative
control.
DNAse I Footprinting
DNAse I footprinting was carried out by a modification of the method of Galas and Schmitz
(23). Standard binding reactions (120 t1l) contained 6.1 % glycerol/39 mM KCI/7.2 mM
HEPES, pH 7.94/70 ,uM EDTA/70 ltM EGTA/7.5 mM MgCl2/15 ,ug poly (dI/dC)/32P-
labeled DNA and varying amounts of crude nuclear extract protein. Binding reactions were
incubated at room temperature for 30 minutes, followed by the addition of 2 mM CaCl2
and DNAse I. After 4 minutes at room temperature, digestion was stopped by the addition
of a mix containing 100 mM Tris, pH 8/100 mM NaCl/20 mM EDTA/0. 1 % SDS/100
mg/ml Proteinase K/100 Ag/ml glycogen. Following a 20 minute incubation at 37°C, the
samples were extracted with phenol/chloroform and ethanol precipitated. The pellets were
resuspended in 7 M urea dye and electrophoresed on an 8% polyacrylamide/7 M urea
sequencing gel at 55 watts constant power in 0.5 xTBE buffer. Sequencing reactions were
prepared as described by Maxam and Gilbert (24) and were run in parallel with footprinting
reactions to precisely localize protected sequences. The gels were exposed overnight to
XRP film with an intensifying screen at -70°C.
In Vitro Transcription Assays
Transcription reactions (25 I1 final volume) were performed essentially as described by
Manley (25) in a buffer consisting of 400 ytM ATP/400 ,M UTP/400 jtM CTP/50 .uM
32P-GTP (10 ,uCi, 3000 Ci/mmol)/I mM creatine phosphate/140 ,tM EDTA. Reactions
were initiated by the addition of template DNA (0.5 -2.0 jig) and 15,l of nuclear extract
(100-150 yg of protein). Template DNA was linearized by restriction digestion to produce
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a discrete sized transcript. Following a 60 minute incubation at 30°C, the reaction was
stopped by the addition of buffer containing 8 M urea/0.5% SDS/10 mM EDTA/10 mM
Tris, pH 8.0. An internal standard of a 494 base Sp6 transcript (supplied by Dr. R. Kole)
was added to each sample to detect differences in recovery during the extraction process.
The samples were extracted with sodium acetate-saturated phenol/chloroform, back extracted
and then re-extracted with phenol/chloroform. RNA was ethanol precipitated and separated
on a 4% polyacrylamide/7 M urea gel in 0.5 x TBE buffer. The RNA products were
visualized by direct autoradiography for 16-40 hours on XRP film. Size markers consisted
of the 494 nucleotide transcript and end-labeled Hae Ill $X174. Transcript production
was quantitated by densitometry on X-ray films using an LKB Ultrascan densitometer.
Transfection and CAT Assays
HeLa cells were grown in monolayer in Eagles MEM supplemented with 10% HyClone
calf serum. The DHFR promoter-CAT constructs were transfected into HeLa cells by
CaPO4 coprecipitation essentially as described by Graham and van der Eb (26). The DNA
(10 jig) was precipitated for 30 minutes in Hepes buffered saline (HeBS, 20 mM Hepes,
pH 7.1/ 0.1% dextrose/138 mM NaCl/4.9 mM KCI/0.7 mM NaHPO4) by the addition
of CaCl2 to 6.0 mM. The DNA precipitate in 500 IAl was overlayed onto a washed well-
drained monolayer containing ca. 1 x 106 cells per 10 cm dish. Completed media was
added after 30 minutes. Four hours later, medium was aspirated and replaced with 15%
glycerol in HeBS for 4 min; the monolayer was then washed and complete medium was
added. The cells were incubated for 48 hours prior to harvest and freeze-thaw lysis.
Schneider cells (generously provided by Dr. C. Benyajti) were grown and transfected as
described by DiNocera and Dawid (27). Lysates were assayed for protein content by the
Bradford (28) assay. Lysates (100 jg of HeLa; 40 pAg of Schneider) were assayed for CAT
activity by monitoring conversion of 14C-chloramphenicol to the acetylated forms by TLC
and visualization by autoradiography (29). '4C-chloramphenicol acetylation was
quantitated by scraping spots from TLC plates and measuring radioactivity by liquid
scintillation counting.
Competition for GC Box Binding Proteins
Oligonucleotides containing the Spl consensus binding site (5'GATCGGGGCGGGGC3'
and its complement) and a three base substitution mutant Spl binding site
(5'GATCGGAAAGGGGC3' and its complement) (30) and GC box III
(5'GTGGAGGCGGAGTCTGACCTC3' and its complement) were synthesized with an
Applied Biosystems oligonucleotide synthesizer, and purified by electrophoresis on 20%
acrylamide/7M urea sequencing gels. Full-length oligonucleotide was eluted from the gel
and precipitated by the addition of ethanol. For in vitro transcription, the oligonucleotide
was annealed and used at this step. For co-transfection, the gel purified oligonucleotides
were phosphorylated with T4 kinase, annealed to a complementary oligonucleotide, and
concatenated to a mean size of 200-300 bp with T4 ligase. Molar excess concentrations
of competitor DNAs were based on the number of Spl binding sites. Although there are
no Spl binding sites in the adenovirus major late promoter, the molar equivalent of one
binding site was used to determine whether there was any basal level of nonspecific
competition by the Spl oligonucleotide competitor.
RESULTS
In order to examine DNA/protein interactions and to determine the sequences required
for DHFR transcription, a series of progressive deletions from positions -896 to -103
9294
Nucleic Acids Research
In nn,i . .- ,mLE,








Figure 1. Deletion constructs of the hamster DHFR gene promoter. The constructs used in the experiments are
all cloned in pUC 18 and the DHFR position number is relative to AUG being at + 1. The orientation of all
the clones is with the Hind III site of pUC 18 3' to the start of transcription, and the 3' end of the constructs
is at position -22 or -16. The 5' ends are at the positions designated by the clone name, and the constructions
were made as described in the methods. These constructs have all been cloned 5' to the bacterial chloramphenicol
acetyl transferase (CAT) gene. Conserved sequence elements are indicated by boxes. The solid boxes are GC
elements while the open boxes are GC elements on the opposite strand; the split box is a GC element that does
not appear to bind Spl. The cross hatched box was previously designated element 2. The open boxes below
the line are inverted repeats of one another, designated element 5, and the striped boxes below the line are direct
repeats designated element 3. Arrows indicate the major and minor transcription start sites at positions -63 and
-107 respectively. The brackets below the first line show regions of DNAse I footprinting.
relative to the translation start site of the Chinese hamster DHFR gene were subcloned
into pUC18 from a 1290 bp Eco RI fragment previously described (4). The 3' end of
the subcloned fragments terminate at positions -22 (Sty I) or a -16 (Sau 3a I) relative
to AUG; these are shown in Figure 1. The chloramphenicol acetyl transferase (CAT) gene
including the polyadenylation signal from pSV2CAT have been subcloned 3' to these various
deletion constructs.
DNA Binding Assays
Protein-DNA interactions were examined by DNAse I footprinting assays with HeLa cell
crude nuclear extracts. Multiple regions were protected in the -22 to -239 fragment;
the footprint of the lower strand is shown in figure 2. A 39 bp protected region from -158
to -197 corresponds to GC elements III and IV. A protected region spanning -142 to
- 158 includes GC element II. The footprint extending from -99 to -118 contains GC
element I. Although the resolution of the gel shown in figure 2 does not allow determination
of the precise boundaries of the GCbox I footprint, the detailed mapping of this footprint
has been defined previously (19), and the correct numbering is shown in figure 2. The
footprints are asymmetric over the GC elements; on the 5' to 3' strand the footprints extend
over GC element I from -95 to -116, and from -136 to -201 over GC elements II,
III and IV (data not shown). Titration of nuclear extract did not reveal any obvious
preferential binding among these GC elements; they all were first visualized using 60 itg
of extract protein, and the footprints did not change with additional protein up to 480 tg.
Complementary single-stranded oligonucleotides to the consensus Sp 1 binding site (30)




Figure 2. DNAse I footprinting of the DHFR promoter with titrated crude HeLa nuclear extract. The 217 bp
insert was excised with Eco RI and Pst I from pDHF-239 and was labeled by filling in the Eco RI recessed
end, thus specifically labelling the 3'-5' (lower) strand. Sequencing and footprinting reactions were perfomed
essentially as described by Galas and Schmitz. Reactions contained 15 jig poly dI/dC, 5 ng labeled DNA probe,
and increasing amounts of nuclear extract protein. The first lane shows the G+A reaction; the second lane is
the cleavage by DNAse I in the absence of protein, and the remaining lanes are a protein titration from 15 through
480 jig, doubling the amount of protein in each lane. Footprinted regions are indicated by the brackets to the
right of the photograph. Position numbers are consistent with the text and relative to +1 being the ftraslation star.
DNA.- Addition of SpI element oligonucleotide to footprinting reactions competed the
formnation of footprints over the GC2 elements (data not shown). The positions of the protein
binding regions revealed by footprinting analysis of the remainder of the 5' flanking sequence




-c~~0 C'J co Cm CNJ Lf cr
- ,- CXN cn -T co
Figure 3 In vitro transcription of the DHFR promoter deletion constructs. The CAT construct clones diagrammed
in Figure 1 were linearized with Sca I and transcribed in HeLa nuclear extract as described in the methods to
yield a 736 nucleotide major transcript. The clones transcribed are indicated above the lane. A 494 nt Sp6 transcript
is included to monitor recovery of RNA.
Analysis of Sequence Requirements for DHFR Transcription.
In order to determine the minimal amount of 5' flanking sequence required for DHFR
transcription in vitro, transcription mun-off assays were performed using the DHFR deletion
constructs whose 5' end varied from position -896 to -103. Runoff transcripts were
visualized by direct autoradiography of denaturing polyacrylamide gels. Templates were
linearized 3' to the promoter within the pUC sequence to assess the accuracy of transcription.
Figure 3 show the results of transcription of the cloned promoter fragments linearized
with Sca I to produce 972 (major) and 1016 (minor) nucleotide transcripts. Utilization
of the major and minor start sites was determined by densitometric measurements on the
autoradiograms and was found to be 4:1, consistent with their relative utilization in vivo.
The transcripts were sensitive to low levels of ca-amanitin, indicative of polymerase U
transcription (data not shown). The two shortest clones containing no (pDHF-103) and
one (pDHF-120) GC element did not transcribe in vitro using conditions that we had
determiined to be optimal for DHFR transcription. The maximal level of in vitro transcription
was consistently achieved with pDHF-184, which contains 3 GC elements. Transcription
assays done on larger promoter fragments did not result in increased transcript production.
In some experiments, pDHF-239 was up to 2-fold higher in transcript production than
the -184 clone, but this was not a consistent finding. The adenovirus major late promoter
(AdMLP, generously provided by Dr. Phil Sharp, MMT was included as a positive control
and served to indicate the relative activity of the DHFR promoter. AdMLP, which has
also been designated pFLBH (31), was linearized with Pst I to produce a 962 nt transcript
(Fig. 3). In contrast to a previous report (20), the conditions (Mg+ +, ATP, and template
concentration) for maximal in vitro transcription were found to be the same for pDHF-239
and AdMLP. Furthermore, the major and minor start sites were proportionately utilized
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Figure 4. Transient expression from the DHFR promoter deletion constructs. pDHF/CAT constructs (10 g)
containing DHFR 5' sequences extending to the indicated position were transfected by the calcium phosphate
procedure into HeLa cells as described in the methods section. The bar diagram shows the results with the standard
error of the mean of 4 separate experiments; bars with the * are not significantly different from one another,
but are significantly greater than those without stars, which are not different from one another (P <0.01).
Analysis ofthe Sequence Requirementsfor Transient Expressionfrom the DHFR Promoter.
To further assess the sequence requirements for DHFR expression in vivo, the DHFR
deletion constructs were linked to the bacterial chloramphenicol acetyl transferase (CAT)
gene, and transfected into HeLa cells. The results obtained from these transient expression
assays were consistent with those from in vitro transcription assays (Fig. 4) The two shortest
constructs, which extended to position -103 and -120 and were inactive in in vitro
transcription, resulted in very low levels of CAT activity. These were equivalent to or
less than background levels arising from a promoter-less pUC 18 CAT construct, used as
a negative control. Clones containing 3 or more GC elements expressed CAT equally well.
The Effect of Competition with Sp 1 Element Oligonucleotide on In Vitro Transcription
and Transient Expression.
The significance of GC elements in DHFR transcription was suggested by the functional
analysis of deletion constructs. The role of factor(s) binding to GC elements was then tested
by competition experiments. Double-stranded oligonucleotides to the consensus Spl binding
site were pre-incubated with nuclear extract followed by addition of template DNA to in
vitro transcription reactions. Transcription of pDHF-239 was reduced 50% by a six-fold
molar excess of Sp 1 element oligonucleotide and was abolished by addition of a 20-fold
excess of competitor (Figure 5A). Addition of up to a 300-fold excess of Sp 1 element
oligonucleotide had no inhibitory effect on adenovirus major late promoter transcription,
and addition of up to 2 jig poly dI/dC had no effect on specific transcription from either
template (data not shown). Furthermore, addition of double stranded mutant Sp 1 element
oligonucleotide (5'GATCGGAAAGGGGC3') had no effect on the transcription of
pDHF-239 (data not shown). In vitro transcription of the SV40 early promoter was also
competed by addition of Sp 1 element oligonucleotide, but a 200-fold molar excess
(calculated on the basis of the 5 utilized Spl binding sites) was required (Figure 5B). The
same results were obtained when concatamerized oligonucleotides were tested for their
ability to compete transcription (data not shown).
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Figure 5. Competition of transcription in vitro by Sp 1 element oligonucleotide. A. pDHF-239 was linearized
with Sca I and transcribed in HeLa nuclear extract. Double stranded Sp 1 element oligonucleotide was added
to the nuclear extract at the indicated concentration prior to the addition of template and cocktail and pre-incubated
on ice for 10 minutes. B. pSV2CAT template was linearized with Sca I to produce a 720 nt transcript. Double
stranded Sp 1 element oligonucleotide was added to the reactions as described using the indicated molar excess
of competitor.
To further test the requirement for a factor binding to the GC elements in the DHFR
promoter, the ability of the Sp 1 element to compete for transient CAT expression from
the DHFR promoter was examined. The double stranded Sp 1 element oligonucleotide
was concatamerized by ligation to facilitate CaPO4 precipitate formation as well as to
facilitate transport to the nucleus. Concatamerized Sp 1 element which was 200-600 bp
in length was co-transfected with pDHF-239 CAT. CAT expression was diminished 50%
by cotransfection of 2 yg of oligonucleotide, which is a 16-fold molar excess of Sp 1 element
binding sites relative to pDHF-239CAT, and the inhibition was proportional to the amount
of competitor (Fig. 6). An oligonucleotide containing DHFR GC box IH and conserved
flanking sequence from -158 to -178 was found to inhibit CAT expression to a greater
extent than the Sp 1 element oligonucleotide. The oligonucleotides had no apparent effect
on cell growth. Cotransfection of the Sp 1 element or GC box mI oligonucleotides with
AdMLP/CAT, in the same amounts that inhibited pDHF-239CAT expression, slightly
inhibited AdMLP/CAT expression, but there was no dose-dependence to the AdMLP
inhibition (Fig. 6). In addition, cotransfection of the mutant Sp 1 element oligonucleotide
or poly dI/dC with pDHF-239CAT did not affect CAT expression (data not shown).
Spi-dependent Expression of the Hamster DHFR Promoter in Drosophila Cells.
Schneider cells (generous gift of Dr. C. Benyajti) are a Drosophila melanogaster cell line
that does not have detectable levels of Spl. Courey and Tjian recently showed that co-
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Figure 6. Competition of transient expression from the DHFR promoter by co-transfection of Sp 1 element
oligonucleotide. HeLa cells were transfected with 10 gtg of either the pDHF-239CAT or the adenovirus major
late promoter CAT by calcium phosphate mediated transfection. Sp 1 element or DHFR GC box fi oligonucleotides
were co-transfected with the test promoter in the amounts indicated. Cells were harvested and lysed after 48
hours and CAT activity was measured on tOO /tg of extract protein. The amount of acetylation that was quantitated
by isolating and quantitating radioactivity from TLC plates is indicated.
transfection of a plasmid expressing Spl with the pSV2/CAT construct activated CAT
expression from this promoter which was otherwise not expressed in these cells (32).
Schneider cells were transfected with 20 itg of pSV2CAT, Rous sarcoma virus LTR/CAT,
or pDHF-239CAT. There was no CAT expression from either the DHFR or the SV40
early promoter. When 100 ng of a plasmid construct that expresses Spi (pPacSpl,
generously supplied by Dr. Robert Tjian) was co-transfected with these constructs, CAT
expression from the SV40 early and DHFR promoters was induced (Fig. 7). The RSV
LTR was slightly stimulated, but its activity was very high even in the absence of Spl.
DISCUSSION
DHFR is expressed in all growing cells and is required for the maintenance of cell growth.
The DHFR promoter contains GC elements but lacks canonical TATA and CAAT sequence
elements. In the present study, we have extended earlier studies of the mouse DHFR
promoter in an attempt to determine the regulatory sequence elements and to analyze the
functional significance of binding to the GC elements. Although it has been reported that
one GC element is sufficient for DHFR gene transcription in vitro (20), all of the promoters
in which they have been found in the absence ofTATA and CAAT elements contain multiple
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Figure 7. Transient expression of the DHFR promoter in Schneider cells. Schneider cells were transfected with
20 1g of the indicated promoter/CAT construct. 100 ng of the Spl expression plasmid (pPacSpl) was co-transfected
with the test plasmid in the indicated samples (+). Forty-eight hours after transfection, cells were lysed by repeated
freeze-thaw cycles; the lysate was assayed for protein content and 40 Ag of lysate was assayed for CAT activity.
GC elements. We have demonstrated by oligonucleotide competition of in vitro transcription
and transient expression that DHFR transcription is dependent upon the binding of a factor(s)
to the GC elements. Inclusion of additional 5' flanking sequence distal to -184 does not
increase transcription in our assays, even though additional GC elements are contained
within these sequences. These distal GC elements may be involved in regulation of a
divergent transcript from this region (33).
There are four GC boxes in the proximal region of the Chinese hamster DHFR gene
promoter (4,5) that are also found in the mouse DHFR promoter. The human DHFR
promoter has two GC boxes (6). In addition there is conserved sequence flanking the GC
boxes I and II, which we previously designated consensus element 3 (4). Within each element
3, there is a CAAGT positioned 29 bp upstream from both the major and minor transcription
start sites. There is an additional conserved sequence element between -47 and -65,
which was previously designated consensus element 2, present in all of the clones analyzed
in this report. The spacing between consensus elements 2 and 3 is conserved. We have
examined specific DNA/protein interactions within the DHFR promoter by DNAse I
footprinting. In the promoter clone that produces the highest activity, extending to -239,
there are five resolvable elements of DNA/protein interaction; four of these contain GC
elements. An additional interaction was detected over consensus element 2, and is described
in detail elsewhere (19). No preference was seen among the four proximal GC elements
by titration of protein in footprinting experiments. This is in contrast to results reported
with the SV40 early promoter in which there is preferential binding among the sites (34).
In this paper, we present data on in vitro transcription of the DHFR promoter. In contrast
to an earlier report (20), we find that the optimal conditions, as defined by maximal
production of correct sized transcripts, for DHFR transcription are the same as those for
transcription of the adenovirus major late promoter. The optimal template concentration
varied somewhat among extracts (20 to 80 mg/ml, 1-4 mM), and was the same within
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an extract regardless of the template. We have observed the use of both the major and
minor start sites using linearized templates, and we have found no difference in the results
with supercoiled plasmid template analyzed by primer extension.
In our experiments using deletion constructs of the DHFR promoter, a template with
one intact GC element did not transcribe accurately in vitro using several different assay
conditions. When the pDHF-120 construct was linearized with EcoRi , which cuts 11
bp 5' to position -120, thereby providing an accessible 5' end near the transcription start,
there was still no transcription in vitro. The pDHF-120 construct was made from pDHF-103
by insertion of an oligonucleotide containing an additional 17 bp of DHFR sequence
including the first GC box. There is 7 bp of additional pUC18 multiple cloning site sequence
between the end of the -103 clone and the 17 bp of DHFR sequence. It is possible that
this additional sequence results in the inability of the -120 clone to transcribe or express,
and this interesting possibility is being explored. We conclude that accurate transcription
in vitro from the hamster DHFR promoter requires more than one GC element, or that
the spacing within the first GC element or between the GC box and the major transcription
start site is absolutely critical.
Our experiments studying transient expression of a reporter gene driven by varying
amounts ofDHFR promoter support the premise that one GC element may be insufficient
to drive expression. A promoter construct with one GC element (-120) does not express
CAT in HeLa cells. Ciudad et al. (35) have reported that a similar construct (-111)
expresses a DHFR mini gene at a 2-fold lower efficiency than constructs bearing from
-166, -240 or -900 in transfected DHFR-deficient CHO host cells. They also reported
that the minor start is not utilized in a clone that extends to -166. We have observed
use of the minor start in vitro in a clone extending to -184. GC box III (-166 to -175)
may be important in fixing the minor start site.
The necessity for factor(s) binding to GC elements for DHFR gene transcription is
supported by oligonucleotide competition experiments. DHFR transcription was 50%
inhibited by a 6-fold molar excess of of Sp 1 element oligonucleotide competitor, whereas
in vitro transcription of the SV40 early region was not inhibited by a 100-fold molar excess.
A simple interpretation of these data would be that SV40 has a higher affinity for Spl
binding; however, the Spl binding sites in the DHFR promoter are of equal or greater
affinity than those in the SV40 promoter (30). There are plausible explanations for the
differences in competition stoichiometry between DHFR and SV40 transcription. Spl may
be responsible for the footprint over the GC element; however, a different rate-limiting
protein may interact with Spl to increase DHFR transcription in a manner analogous to
APl/fos (36,37). The remainder of the conserved sequence surrounding the GC boxes
I and II (element 3) may interact with an additional factor required for transcription that
is cooperatively involved in the binding of Spl. In addition, there are also several other
transcription factors known to be involved in SV40 early transcription, so that the absolute
requirement for Spl may be less stringent. The requirement for GC element binding was
confirmed in cells. Co-transfection of concatamerized Spl oligonucleotide inhibited CAT
expression from the DHFR promoter. Microinjection of Sp 1 element oligonucleotide was
shown to inhibit b-crystalline gene expression in the lens (38); however, co-transfection
is a simpler procedure.
A fraction of HeLa cell nuclear extract enriched for Spl binds to the murine DHFR
promoter and stimulates DHFR gene transcription in vitro when added to extracts from
which it has been depleted (21). Since this fraction is not pure, we looked directly at the
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effect of Spl on DHFR expression in cells that have no Spl. In an experiment similar
to that reported by Courey and Tjian (32) using pSV2CAT, we have shown that CAT
expression from the DHFR promoter in Spl-deficient cells is not detectable, but that co-
transfection of an Spl expressor dramatically increased transient expression. The data
presented herein support the premise that the GC elements and a factor(s) that binds to
these sequences are absolutely required for constitutive DHFR gene expression. Spl is
sufficient to restore DHFR promoter activity in a cell that does not express the promoter
in its absence.
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